BR9704637A - Processo para deteção de mutações induzidas por droga no gene de transcrição reversa - Google Patents

Processo para deteção de mutações induzidas por droga no gene de transcrição reversa

Info

Publication number
BR9704637A
BR9704637A BR9704637A BR9704637A BR9704637A BR 9704637 A BR9704637 A BR 9704637A BR 9704637 A BR9704637 A BR 9704637A BR 9704637 A BR9704637 A BR 9704637A BR 9704637 A BR9704637 A BR 9704637A
Authority
BR
Brazil
Prior art keywords
reverse transcription
induced mutations
detecting drug
transcription gene
gene
Prior art date
Application number
BR9704637A
Other languages
English (en)
Inventor
Joost Louwagie
Rudi Rossau
Lieven Stuyver
Original Assignee
Innogenetics Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Innogenetics Nv filed Critical Innogenetics Nv
Publication of BR9704637A publication Critical patent/BR9704637A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/702—Specific hybridization probes for retroviruses
    • C12Q1/703—Viruses associated with AIDS

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • AIDS & HIV (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
BR9704637A 1996-01-26 1997-01-17 Processo para deteção de mutações induzidas por droga no gene de transcrição reversa BR9704637A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP96870005 1996-01-26
EP96870081 1996-06-25
PCT/EP1997/000211 WO1997027332A1 (en) 1996-01-26 1997-01-17 Method for detection of drug-induced mutations in the reverse transcriptase gene

Publications (1)

Publication Number Publication Date
BR9704637A true BR9704637A (pt) 1998-06-09

Family

ID=26144370

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9704637A BR9704637A (pt) 1996-01-26 1997-01-17 Processo para deteção de mutações induzidas por droga no gene de transcrição reversa

Country Status (7)

Country Link
US (3) US6087093A (pt)
EP (1) EP0817866A1 (pt)
JP (1) JPH11502727A (pt)
AU (1) AU719691B2 (pt)
BR (1) BR9704637A (pt)
CA (1) CA2215073A1 (pt)
WO (1) WO1997027332A1 (pt)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6265152B1 (en) * 1995-12-22 2001-07-24 Visible Genetics Inc. Method and kit for evaluation of HIV mutations
US6830887B2 (en) 1997-03-18 2004-12-14 Bayer Healthcare Llc Method and kit for quantitation and nucleic acid sequencing of nucleic acid analytes in a sample
WO1999061658A1 (en) * 1998-05-26 1999-12-02 Virologic, Inc. Means and methods for monitoring non-nucleoside reverse transcriptase inhibitor antiretroviral therapy
US7037644B1 (en) 1998-05-26 2006-05-02 Virologic, Inc. Means and methods for monitoring non-nucleoside reverse transcriptase inhibitor antiretroviral therapy and guiding therapeutic decisions in the treatment of HIV/AIDS
CA2341679A1 (en) * 1998-06-24 1999-12-29 Virologic, Inc. Means and methods for monitoring nucleoside reverse transcriptase inhibitor antiretroviral therapy and guiding therapeutic decisions in the treatment of hiv/aids
US6803187B1 (en) * 1998-06-24 2004-10-12 Innogenetics N.V. Method for detection of drug-selected mutations in the HIV protease gene
BR9911457A (pt) * 1998-06-24 2001-12-11 Univ Emory Uso de 3'-azida-2', 3'-dideoxiuridina em combinaçãocom drogas anti-hiv adicionais para a manufaturade um medicamento para o tratamento de hiv
WO2000040246A1 (en) * 1999-01-08 2000-07-13 University Of Massachusetts Detection of human immunodeficiency virus
DE19921419A1 (de) * 1999-05-08 2000-11-16 Univ Ruprecht Karls Heidelberg Verfahren zum spezifischen Nachweis und zur Identifizierung retroviraler Nukleinsäuren / Retroviren in einem Untersuchungsgut
ES2246859T3 (es) * 1999-05-28 2006-03-01 Virco Bvba Nuevos perfiles mutacionales en la transcriptasa inversa del vih-1 correlacionadas con una resistencia fenotipica a farmacos.
FR2798385B1 (fr) * 1999-06-21 2003-09-05 Bio Merieux Procede de recherche d'une resistance aux anti-proteases chez des souches du virus vih-2
ES2373488T3 (es) 2000-04-18 2012-02-06 Virco Bvba Métodos para medir la resistencia a los fármacos frente a hcv.
CA2406830C (en) * 2000-04-20 2012-10-02 Virco Bvba Method for mutation detection in hiv using pol sequencing
US6800463B1 (en) 2000-04-20 2004-10-05 Virco Bvba Method for mutation detection in HIV-1 using pol sequencing
FR2810049A1 (fr) * 2000-06-09 2001-12-14 Inst Nat Sante Rech Med Methode de detection et/ou de quantification de variants minoritaires au sein d'une population virale heterogene dans un echantillon biologique
CA2411401A1 (en) * 2000-06-12 2001-12-20 Virologic, Inc. Means and methods for monitoring antiretroviral therapy and guiding therapeutic decisions in the treatment of hiv/aids
EP1174518A1 (en) * 2000-07-20 2002-01-23 Amsterdam Support Diagnostics B.V. Collection of binding molecules
AU2002226316B2 (en) 2000-10-20 2008-06-26 Virco Bvba Mutational profiles in HIV-1 reverse transcriptase correlated with phenotypic drug resistance
US7439271B2 (en) * 2001-06-27 2008-10-21 The Gillette Company Reduction of hair growth
AU2003254500B2 (en) 2002-07-01 2009-11-19 Tibotec Pharmaceuticals Ltd. Mutational profiles in HIV-1 protease correlated with phenotypic drug resistance
EP1522039B1 (en) 2002-07-01 2008-06-04 Tibotec Pharmaceuticals Ltd. New mutational profiles in hiv-1 reverse transcriptase correlated with phenotypic drug resistance
JP2005532054A (ja) * 2002-07-01 2005-10-27 バイロロジック，インコーポレーテッド 病原性ウイルスの複製能を決定するための組成物及び方法
CA2490918A1 (en) * 2002-07-01 2004-01-08 Tibotec Pharmaceuticals Ltd. New mutational profiles in hiv-1 reverse transcriptase correlated with phenotypic drug resistance
US6797464B2 (en) * 2002-07-10 2004-09-28 University Of Massachusetts Detection of drug-resistant human immunodeficiency virus
CA2506654C (en) * 2002-11-07 2014-02-25 Yoichi Matsubara Method of detecting gene mutation
US20060257851A1 (en) * 2002-11-26 2006-11-16 Itzhak Bentwich Bioinformatically detectable group of novel viral regulatory genes and uses thereof
WO2005000234A2 (en) * 2003-06-12 2005-01-06 Sars Scientific Corp. Novel coronavirus inhibitors
WO2005071080A2 (en) * 2004-01-20 2005-08-04 Isis Pharmaceuticals, Inc. Modulation of glucocorticoid receptor expression
US20070196902A1 (en) * 2006-01-31 2007-08-23 University Of Pittsburgh Method of detecting AZT resistance in HIV
US8470762B2 (en) * 2007-05-31 2013-06-25 Colgate-Palmolive Company Fabric softening compositions comprising polymeric materials
EP2370580B1 (en) * 2008-12-04 2019-09-11 CuRNA, Inc. Treatment of sirtuin 1 (sirt1) related diseases by inhibition of natural antisense transcript to sirtuin 1
US20110319317A1 (en) * 2009-03-04 2011-12-29 Opko Curna, Llc Treatment of sirtuin 1 (sirt1) related diseases by inhibition of natural antisense transcript to sirt1
ES2854004T3 (es) * 2009-07-24 2021-09-20 Curna Inc Tratamiento de enfermedades relacionadas con Sirtuina 6 (SIRT6) mediante inhibición del transcrito antisentido natural para SIRT6
EP2677321A1 (en) * 2012-06-20 2013-12-25 Innogenetics N.V. Integrated device for nucleic acid hybridizations and immuno-assays

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8918226D0 (en) * 1989-08-09 1989-09-20 Wellcome Found Dna assays
WO1992016180A2 (en) * 1991-03-13 1992-10-01 Siska Diagnostics, Inc. Detection of 3'-azido-3'-deoxythymidine resistance
EP0532258A2 (en) * 1991-09-09 1993-03-17 Immuno Japan Inc. Oligonucleotides and determination system of HCV genotypes
GB9208000D0 (en) * 1992-04-10 1992-05-27 Univ London Quantitative viral assay
GB9210176D0 (en) * 1992-05-12 1992-06-24 Cemu Bioteknik Ab Chemical method
AU4248593A (en) * 1992-05-14 1993-12-13 Mark Holodniy Polymerase chain reaction assays for monitoring antiviral therapy
ATE174382T1 (de) * 1992-10-06 1998-12-15 Dade Behring Marburg Gmbh Retrovirus aus der hiv-gruppe und dessen verwendung
ATE507312T1 (de) * 1992-11-27 2011-05-15 Innogenetics Nv Nachweis und typisierung das hepatitis c virus (hcv) mittels 5'utr und ns5 nukleinsäuresequenzen
US5827648A (en) * 1995-12-13 1998-10-27 Chiron Corporation Differential hybridization for relative quantification of variant populations

Also Published As

Publication number Publication date
EP0817866A1 (en) 1998-01-14
CA2215073A1 (en) 1997-07-31
AU719691B2 (en) 2000-05-18
US20030077575A1 (en) 2003-04-24
JPH11502727A (ja) 1999-03-09
AU1444397A (en) 1997-08-20
US6087093A (en) 2000-07-11
US6713251B2 (en) 2004-03-30
WO1997027332A1 (en) 1997-07-31
US6331389B1 (en) 2001-12-18

Similar Documents

Publication Publication Date Title
BR9704637A (pt) Processo para deteção de mutações induzidas por droga no gene de transcrição reversa
BR9713441B1 (pt) processo para alquilaÇço de hidrocarbonetos.
BR9707608A (pt) Processo para paquemmento em multicamada
IT1292462B1 (it) Composizione catalitica utile nel processo di fischer-tropsch
DE59909994D1 (de) Anordnung zur fahrbahnzustandserkennung
BR9606722B1 (pt) Fibra de vidro refratário de baixa contração e processo para sua produção
BR9913647B1 (pt) polipropileno ramificado e processo para produzir o mesmo.
BR9710301A (pt) Processo para rotular artigos
ATE216704T1 (de) Propiophenonderivate und verfahren zu ihrer herstellung
DE69733416D1 (de) Erythromycine und verfahren zu ihrer herstellung
BR9602889A (pt) Processo e aparelhagem para detecção de microorganismos
ATE289577T1 (de) Trennungsverfahren
DE69720523D1 (de) Polyolefin-polyethylenoxid-mischungen und verfahren zu deren herstellung
BR9708128A (pt) Processo de remoção de mancha de dupla etapa
ID21955A (id) Sistim identifikasi medan
BR9709862A (pt) Processo para produzir partícular poliméricas
PT942794E (pt) Processo para o fabrico de uma peca moldada
BR9509842A (pt) Processo para produção de fosgênio
BR9708865A (pt) Processo para separação solidos/liquidos
BR9703078A (pt) Processo para obtenção de aldeídos
BR9604427A (pt) Aparelho extrusor para mesclado-amassado
BR9815906B1 (pt) método para reduzir as impurezas de uma argila de caulim.
ATE396148T1 (de) Molekularsiebe und verfahren zu deren herstellung
BR9707070A (pt) Processo de separação
DE69941485D1 (de) Biochemischer vorrichtungen und verfahren zu ihrer herstellung

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 8A , 9A E 10A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1882 DE 30/01/2007.